Koshinski Asset Management Inc. Buys Shares of 6,124 SPDR S&P Biotech ETF (NYSEARCA:XBI)

Koshinski Asset Management Inc. purchased a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the second quarter, according to its most recent filing with the SEC. The firm purchased 6,124 shares of the exchange traded fund’s stock, valued at approximately $686,000.

Several other large investors have also recently made changes to their positions in XBI. JPMorgan Chase & Co. increased its holdings in SPDR S&P Biotech ETF by 9,599.3% during the 1st quarter. JPMorgan Chase & Co. now owns 9,853,687 shares of the exchange traded fund’s stock valued at $763,069,000 after acquiring an additional 9,752,095 shares in the last quarter. Morgan Stanley increased its stake in shares of SPDR S&P Biotech ETF by 18.2% during the 1st quarter. Morgan Stanley now owns 9,002,902 shares of the exchange traded fund’s stock worth $697,184,000 after purchasing an additional 1,387,956 shares in the last quarter. SG Americas Securities LLC acquired a new position in shares of SPDR S&P Biotech ETF during the 1st quarter worth approximately $38,742,000. tru Independence LLC lifted its stake in SPDR S&P Biotech ETF by 234.6% in the 1st quarter. tru Independence LLC now owns 378,743 shares of the exchange traded fund’s stock valued at $21,475,000 after buying an additional 265,559 shares in the last quarter. Finally, Meitav Dash Investments Ltd. lifted its stake in SPDR S&P Biotech ETF by 6,965.4% in the 1st quarter. Meitav Dash Investments Ltd. now owns 228,567 shares of the exchange traded fund’s stock valued at $17,700,000 after buying an additional 225,332 shares in the last quarter.

NYSEARCA XBI opened at $109.33 on Friday. SPDR S&P Biotech ETF has a fifty-two week low of $62.94 and a fifty-two week high of $121.06. The business has a fifty day moving average of $111.77 and a 200-day moving average of $96.63.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Further Reading: The benefits and drawbacks of dollar cost averaging

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.